SANDOZ GROUP AG (SDZXF:OTCMKTS)
$81.5 -1.2175 (-1.4719%)
Analysed SANDOZ GROUP AG (SDZXF:OTCMKTS) News Sources
Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz
28-04-2026
yahoo.com
AMRX Growth Drivers: Generics, Biosimilars, and Crexont
28-04-2026
yahoo.com
Amneal 2026-2027 Upside From Biosimilars Scale
28-04-2026
yahoo.com
Assessing Sandoz Group (SWX:SDZ) Valuation After Q1 2026 Biosimilar Growth And Samsung Bioepis Partnership
03-05-2026
yahoo.com
Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?
08-05-2026
yahoo.com
USNA or SDZNY: Which Is the Better Value Stock Right Now?
12-05-2026
yahoo.com
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Buy: Here's What You Should Know
19-05-2026
yahoo.com
SDZNY or UTHR: Which Is the Better Value Stock Right Now?
04-06-2026
yahoo.com
3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
05-06-2026
yahoo.com
embecta appoints Nimish Muzumdar as SVP and President, North America
16-06-2026
yahoo.com
What is the current price of SANDOZ GROUP AG (SDZXF:OTCMKTS)?
The current price of SANDOZ GROUP AG (SDZXF:OTCMKTS) is $81.5.
SANDOZ GROUP AG (SDZXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SANDOZ GROUP AG (SDZXF:OTCMKTS) since the previous trading day is $-1.2175.
SANDOZ GROUP AG (SDZXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SANDOZ GROUP AG (SDZXF:OTCMKTS) since the previous trading day is -1.4719%.
What is the most recent average sentiment score for SANDOZ GROUP AG (SDZXF:OTCMKTS)?
The most recent average sentiment score for SANDOZ GROUP AG (SDZXF:OTCMKTS) is 76 out of 100.
What is the most recent average sentiment for SANDOZ GROUP AG (SDZXF:OTCMKTS)?
The most recent sentiment for SANDOZ GROUP AG (SDZXF:OTCMKTS) is .
SEC-8K** Filing Available For SANDOZ GROUP AG (SDZXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.